Close X

The myESMO community is an international network of over 6'000 oncology professionals, sharing best practices and the latest know-how in cancer treatment and care

Join myESMO
to access our members only benefits

Click to discover ESMO

Already have an
ESMO Account?

 
Username: Password:
Remember me!
Forgot your Password?
Close X

You are trying to access a members only resource.
Please log-in.

 
Username: Password:
Remember me!

Forgot your Password?

join us

Not a Member yet?

Get involved, stay connected:
Join myESMO community today

TRU visit reports

Untitled Document

Period

Institute

Where

Topic

27-30 October, 2009 Institute Curie Paris, France Translational Research in Breast Cancer
Including: Tumor profiling, circulating tumor cells and disseminated tumor cells: detection, prognostic value, potential marker to monitor the efficacy of treatment, clinical grafts: a tool for defining new drugs association and new targets, epigenetic in Breast cancers, hereditary breast cancers
23-25 March, 2009 Jules Bordet Institute

Brussels, Belgium

Integrating tumor profiling, tumor microenvironment and minimal residual disease to predict clinical outcome and response to various therapeutics in breast cancer patients.
6-9 October, 2008 Instituto Nazionale Tumori Milan, Italy Soft tissue sarcomas, GIST and melanoma.
21-24 April, 2008 I.O.S.I. Bellinzona, Switzerland Translational studies and new drug development in Oncology: the laboratory-clinical interface.
16-19 April, 2007 Norwegian Radium Hospital Oslo, Norway New avenues in molecular diagnostics, immunotherapy, micro-metastases and tumor stem cells.
14-16 February, 2007 Vall d’Hebron Hospital Barcelona, Spain Early Clinical Development of Molecular Targeted Therapies.
23-26 March, 2006 Institut Gustave Roussy Villejuif, France How to succeed in translational research.
21-24 February 2006 Cancer Centre Karolinska Stockholm, Sweden Tumor immunology and immunotherapy.
13-15 April, 2005 Vall d’Hebron Hospital Barcelona, Spain Early Clinical Development of Molecular Targeted Therapies.
23-25 February, 2005 Radcliffe Infirmary Oxford, UK Gene Therapy for Cancer.
21-23 April, 2004 Karolinska Institute Stockholm, Sweden Tumor immunology and immunotherapy.